AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 m 2 of manufacturing, quality control and …
( read original story …)
The Shanghai News
AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 m 2 of manufacturing, quality control and …
( read original story …)